

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sodium ion export (GO:0071436) | 6.70866729 |
| 2 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.79098765 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.76277467 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.69061862 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.63975056 |
| 6 | vocalization behavior (GO:0071625) | 5.63797996 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.33611511 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.19893366 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.15570866 |
| 10 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.10821444 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.10254051 |
| 12 | glutamate secretion (GO:0014047) | 5.06837276 |
| 13 | protein localization to synapse (GO:0035418) | 5.03062970 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.94532247 |
| 15 | cell communication by electrical coupling (GO:0010644) | 4.90487375 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 4.82811249 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.81133313 |
| 18 | locomotory exploration behavior (GO:0035641) | 4.77168224 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.72925760 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.72350215 |
| 21 | neuron-neuron synaptic transmission (GO:0007270) | 4.68589521 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.65920300 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.63049084 |
| 24 | L-amino acid import (GO:0043092) | 4.56652574 |
| 25 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.54151861 |
| 26 | cellular sodium ion homeostasis (GO:0006883) | 4.52829508 |
| 27 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.52775484 |
| 28 | synaptic vesicle maturation (GO:0016188) | 4.52553777 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.51491475 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.28517808 |
| 31 | regulation of synaptic vesicle transport (GO:1902803) | 4.27785094 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.26641465 |
| 33 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.26345416 |
| 34 | potassium ion import (GO:0010107) | 4.25719005 |
| 35 | cell communication involved in cardiac conduction (GO:0086065) | 4.23299289 |
| 36 | presynaptic membrane assembly (GO:0097105) | 4.22284561 |
| 37 | potassium ion homeostasis (GO:0055075) | 4.17893789 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.16336268 |
| 39 | neurotransmitter secretion (GO:0007269) | 4.15913718 |
| 40 | response to histamine (GO:0034776) | 4.15604932 |
| 41 | long-term synaptic potentiation (GO:0060291) | 4.06077763 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 4.02482086 |
| 43 | * gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.02171139 |
| 44 | exploration behavior (GO:0035640) | 4.00552106 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.97713780 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.94264903 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 3.94003127 |
| 48 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.92569965 |
| 49 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.90528823 |
| 50 | regulation of synaptic plasticity (GO:0048167) | 3.90108144 |
| 51 | presynaptic membrane organization (GO:0097090) | 3.89250283 |
| 52 | detection of calcium ion (GO:0005513) | 3.85681483 |
| 53 | relaxation of cardiac muscle (GO:0055119) | 3.85382494 |
| 54 | long-term memory (GO:0007616) | 3.85199063 |
| 55 | amino acid import (GO:0043090) | 3.84097673 |
| 56 | postsynaptic membrane organization (GO:0001941) | 3.83614083 |
| 57 | positive regulation of membrane potential (GO:0045838) | 3.82093482 |
| 58 | behavioral fear response (GO:0001662) | 3.78547439 |
| 59 | behavioral defense response (GO:0002209) | 3.78547439 |
| 60 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.77766069 |
| 61 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.76441989 |
| 62 | behavioral response to cocaine (GO:0048148) | 3.72828524 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.71363664 |
| 64 | regulation of glutamate secretion (GO:0014048) | 3.70624609 |
| 65 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.68957773 |
| 66 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.67887176 |
| 67 | transmission of nerve impulse (GO:0019226) | 3.66707605 |
| 68 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.66604110 |
| 69 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.65887984 |
| 70 | neuron recognition (GO:0008038) | 3.58254324 |
| 71 | fear response (GO:0042596) | 3.53028227 |
| 72 | positive regulation of neurotransmitter transport (GO:0051590) | 3.46310697 |
| 73 | striatum development (GO:0021756) | 3.40672120 |
| 74 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.39787978 |
| 75 | neurotransmitter uptake (GO:0001504) | 3.39355940 |
| 76 | synaptic transmission, dopaminergic (GO:0001963) | 3.38442810 |
| 77 | regulation of cell communication by electrical coupling (GO:0010649) | 3.37820033 |
| 78 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.37774862 |
| 79 | neurotransmitter transport (GO:0006836) | 3.37729698 |
| 80 | central nervous system myelination (GO:0022010) | 3.37654380 |
| 81 | axon ensheathment in central nervous system (GO:0032291) | 3.37654380 |
| 82 | auditory behavior (GO:0031223) | 3.37329937 |
| 83 | negative regulation of amino acid transport (GO:0051956) | 3.36764157 |
| 84 | cellular potassium ion homeostasis (GO:0030007) | 3.36524934 |
| 85 | long term synaptic depression (GO:0060292) | 3.36172291 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 3.35210767 |
| 87 | membrane depolarization (GO:0051899) | 3.34190798 |
| 88 | cerebellar granule cell differentiation (GO:0021707) | 3.31457384 |
| 89 | learning (GO:0007612) | 3.30936445 |
| 90 | startle response (GO:0001964) | 3.29950605 |
| 91 | dendritic spine morphogenesis (GO:0060997) | 3.28046496 |
| 92 | primary amino compound metabolic process (GO:1901160) | 3.25794214 |
| 93 | regulation of dendritic spine development (GO:0060998) | 3.25216407 |
| 94 | regulation of female receptivity (GO:0045924) | 3.24914024 |
| 95 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.24803478 |
| 96 | mechanosensory behavior (GO:0007638) | 3.24390468 |
| 97 | synaptic vesicle endocytosis (GO:0048488) | 3.23836244 |
| 98 | regulation of vesicle fusion (GO:0031338) | 3.23827257 |
| 99 | C4-dicarboxylate transport (GO:0015740) | 3.21805733 |
| 100 | neuronal ion channel clustering (GO:0045161) | 3.21506761 |
| 101 | positive regulation of dendritic spine development (GO:0060999) | 3.20637345 |
| 102 | serotonin metabolic process (GO:0042428) | 3.19908501 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 3.19686826 |
| 104 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.18920298 |
| 105 | regulation of neurotransmitter transport (GO:0051588) | 3.18798246 |
| 106 | axonal fasciculation (GO:0007413) | 3.18621509 |
| 107 | regulation of neurotransmitter levels (GO:0001505) | 3.18447480 |
| 108 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.18201453 |
| 109 | regulation of synapse maturation (GO:0090128) | 3.16731754 |
| 110 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.16322421 |
| 111 | activation of protein kinase A activity (GO:0034199) | 3.13824839 |
| 112 | regulation of synaptic transmission (GO:0050804) | 3.13644067 |
| 113 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.12789269 |
| 114 | female mating behavior (GO:0060180) | 3.12144176 |
| 115 | * synaptic transmission (GO:0007268) | 3.12101178 |
| 116 | response to auditory stimulus (GO:0010996) | 3.11609572 |
| 117 | proline transport (GO:0015824) | 3.09816301 |
| 118 | membrane hyperpolarization (GO:0060081) | 3.09342393 |
| 119 | layer formation in cerebral cortex (GO:0021819) | 3.08530577 |
| 120 | prepulse inhibition (GO:0060134) | 3.07519332 |
| 121 | acidic amino acid transport (GO:0015800) | 3.04161650 |
| 122 | neuromuscular process controlling balance (GO:0050885) | 3.03850683 |
| 123 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.03635118 |
| 124 | response to amphetamine (GO:0001975) | 3.03503468 |
| 125 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.03493676 |
| 126 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.03224524 |
| 127 | membrane depolarization during action potential (GO:0086010) | 3.01756107 |
| 128 | negative regulation of dendrite development (GO:2000171) | 3.01453936 |
| 129 | regulation of protein kinase A signaling (GO:0010738) | 2.97954571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.14725427 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.27796507 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.25325935 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.17605401 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11812590 |
| 6 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.74631536 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69811548 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69811548 |
| 9 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.69273318 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.66221854 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65050967 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53893252 |
| 13 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52770040 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48569030 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45236285 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41710977 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38298931 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.36748068 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.21433180 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15539263 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13518567 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13492591 |
| 23 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.09788879 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09335220 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.05243023 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.99574123 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.99533062 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.92569324 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88261979 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87033145 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.84386182 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.82980708 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81317468 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.79989447 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75314378 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71024640 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66299612 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61026121 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55003132 |
| 40 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52732969 |
| 41 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47368537 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45669109 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43099321 |
| 44 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42920222 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42175402 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41154722 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40767486 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37425736 |
| 49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36351534 |
| 50 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.36190880 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35812955 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35385306 |
| 53 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33287654 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32287840 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29974751 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28853560 |
| 57 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.28642994 |
| 58 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28194551 |
| 59 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26332310 |
| 60 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25898729 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23749292 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22198038 |
| 63 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21475825 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18844857 |
| 65 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18633009 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17507283 |
| 67 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.17233167 |
| 68 | AR_19668381_ChIP-Seq_PC3_Human | 1.16218555 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14794916 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14396897 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14356734 |
| 72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.13449389 |
| 73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12342483 |
| 74 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11644672 |
| 75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11203224 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10458066 |
| 77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09428394 |
| 78 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09314495 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08582889 |
| 80 | JUN_21703547_ChIP-Seq_K562_Human | 1.08171455 |
| 81 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07879881 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07291172 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05722595 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05694515 |
| 85 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05095155 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04641791 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03976066 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02872908 |
| 89 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02859476 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02407194 |
| 91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02303311 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02193706 |
| 93 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01688668 |
| 94 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00367120 |
| 95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00234226 |
| 96 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99800435 |
| 97 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98715022 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98597314 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98530211 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98313002 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97437066 |
| 102 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96534298 |
| 103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96268228 |
| 104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96133670 |
| 105 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95613826 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94081640 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93206780 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92271936 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92271936 |
| 110 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91684926 |
| 111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90976083 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90863137 |
| 113 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.90104015 |
| 114 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89356411 |
| 115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89133091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.43814881 |
| 2 | MP0003880_abnormal_central_pattern | 5.95192583 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.29322356 |
| 4 | * MP0009745_abnormal_behavioral_response | 3.82114536 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.56670954 |
| 6 | MP0002822_catalepsy | 3.55499911 |
| 7 | MP0002064_seizures | 3.41358665 |
| 8 | MP0009046_muscle_twitch | 3.31505968 |
| 9 | MP0004270_analgesia | 3.29653631 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.14598041 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 3.00912447 |
| 12 | MP0002272_abnormal_nervous_system | 2.70601317 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.66082672 |
| 14 | MP0001486_abnormal_startle_reflex | 2.57649026 |
| 15 | MP0002736_abnormal_nociception_after | 2.55924700 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.27845486 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.24242718 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.20208284 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.10857715 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.09291186 |
| 21 | MP0003329_amyloid_beta_deposits | 1.85857267 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.85304492 |
| 23 | MP0001529_abnormal_vocalization | 1.81949691 |
| 24 | MP0003879_abnormal_hair_cell | 1.80170614 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.78750725 |
| 26 | MP0004924_abnormal_behavior | 1.77342724 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.77342724 |
| 28 | * MP0001970_abnormal_pain_threshold | 1.74169560 |
| 29 | * MP0002733_abnormal_thermal_nociception | 1.72956971 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.72829229 |
| 31 | MP0004147_increased_porphyrin_level | 1.71200904 |
| 32 | MP0002184_abnormal_innervation | 1.67134502 |
| 33 | MP0001984_abnormal_olfaction | 1.65711104 |
| 34 | MP0000778_abnormal_nervous_system | 1.65242939 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.63390741 |
| 36 | MP0008569_lethality_at_weaning | 1.62684716 |
| 37 | MP0003787_abnormal_imprinting | 1.62380333 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.52503856 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.52395319 |
| 40 | MP0001188_hyperpigmentation | 1.49955752 |
| 41 | MP0001905_abnormal_dopamine_level | 1.48454888 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.38249057 |
| 43 | MP0000955_abnormal_spinal_cord | 1.33988597 |
| 44 | MP0004142_abnormal_muscle_tone | 1.31459764 |
| 45 | MP0003633_abnormal_nervous_system | 1.28911858 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.27598670 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.27307175 |
| 48 | MP0004858_abnormal_nervous_system | 1.25867776 |
| 49 | MP0004885_abnormal_endolymph | 1.24710423 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.15786857 |
| 51 | MP0003122_maternal_imprinting | 1.13720940 |
| 52 | MP0000751_myopathy | 1.09937574 |
| 53 | MP0003631_nervous_system_phenotype | 1.09586867 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.09110239 |
| 55 | MP0004084_abnormal_cardiac_muscle | 1.08941924 |
| 56 | MP0008872_abnormal_physiological_respon | 1.08072178 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.05010854 |
| 58 | MP0002152_abnormal_brain_morphology | 1.00680601 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.00201889 |
| 60 | MP0008874_decreased_physiological_sensi | 0.98853709 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 0.98545257 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.95865135 |
| 63 | MP0001348_abnormal_lacrimal_gland | 0.95208428 |
| 64 | MP0004130_abnormal_muscle_cell | 0.93499487 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 0.93009085 |
| 66 | MP0002069_abnormal_eating/drinking_beha | 0.91324405 |
| 67 | MP0004085_abnormal_heartbeat | 0.89961174 |
| 68 | MP0005171_absent_coat_pigmentation | 0.89474014 |
| 69 | MP0001963_abnormal_hearing_physiology | 0.86642005 |
| 70 | MP0010386_abnormal_urinary_bladder | 0.86390973 |
| 71 | MP0005535_abnormal_body_temperature | 0.85639674 |
| 72 | MP0002229_neurodegeneration | 0.84120241 |
| 73 | MP0004036_abnormal_muscle_relaxation | 0.83717927 |
| 74 | MP0001485_abnormal_pinna_reflex | 0.83354004 |
| 75 | MP0004742_abnormal_vestibular_system | 0.83108889 |
| 76 | MP0001664_abnormal_digestion | 0.83101083 |
| 77 | MP0000604_amyloidosis | 0.82952474 |
| 78 | MP0001177_atelectasis | 0.82511756 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.81950626 |
| 80 | MP0003075_altered_response_to | 0.79014508 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.78399228 |
| 82 | MP0004484_altered_response_of | 0.77857476 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.74936023 |
| 84 | MP0005409_darkened_coat_color | 0.74812514 |
| 85 | MP0004233_abnormal_muscle_weight | 0.74105263 |
| 86 | MP0003123_paternal_imprinting | 0.73839612 |
| 87 | MP0003632_abnormal_nervous_system | 0.71376704 |
| 88 | MP0005499_abnormal_olfactory_system | 0.70148113 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.70148113 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.69598107 |
| 91 | MP0001346_abnormal_lacrimal_gland | 0.64066138 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.63939473 |
| 93 | MP0003690_abnormal_glial_cell | 0.62909680 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 0.62159746 |
| 95 | MP0002090_abnormal_vision | 0.60851853 |
| 96 | MP0003634_abnormal_glial_cell | 0.59213086 |
| 97 | MP0000569_abnormal_digit_pigmentation | 0.58111680 |
| 98 | MP0000579_abnormal_nail_morphology | 0.57992495 |
| 99 | MP0004043_abnormal_pH_regulation | 0.57086898 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.54575210 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.54446504 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.54286224 |
| 103 | MP0000920_abnormal_myelination | 0.54189558 |
| 104 | MP0010768_mortality/aging | 0.54123899 |
| 105 | MP0005620_abnormal_muscle_contractility | 0.53758267 |
| 106 | MP0000026_abnormal_inner_ear | 0.53169754 |
| 107 | MP0001943_abnormal_respiration | 0.52559285 |
| 108 | MP0001299_abnormal_eye_distance/ | 0.51692502 |
| 109 | MP0004510_myositis | 0.51100558 |
| 110 | MP0003956_abnormal_body_size | 0.48339315 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.47794784 |
| 112 | MP0010770_preweaning_lethality | 0.47342625 |
| 113 | MP0002082_postnatal_lethality | 0.47342625 |
| 114 | MP0010769_abnormal_survival | 0.47031327 |
| 115 | MP0008961_abnormal_basal_metabolism | 0.46015075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.71510174 |
| 2 | Focal seizures (HP:0007359) | 6.19894595 |
| 3 | Myokymia (HP:0002411) | 6.14156044 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.97803260 |
| 5 | Atonic seizures (HP:0010819) | 5.84805678 |
| 6 | Febrile seizures (HP:0002373) | 5.08693728 |
| 7 | Hyperventilation (HP:0002883) | 4.99418031 |
| 8 | Absence seizures (HP:0002121) | 4.86633529 |
| 9 | Visual hallucinations (HP:0002367) | 4.80627428 |
| 10 | Dialeptic seizures (HP:0011146) | 4.57509677 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.23604742 |
| 12 | Broad-based gait (HP:0002136) | 4.12045343 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.97800023 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.74935871 |
| 15 | Poor eye contact (HP:0000817) | 3.57474630 |
| 16 | Amblyopia (HP:0000646) | 3.45579971 |
| 17 | Dysdiadochokinesis (HP:0002075) | 3.36316047 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.22089560 |
| 19 | Abnormal social behavior (HP:0012433) | 3.19453706 |
| 20 | Impaired social interactions (HP:0000735) | 3.19453706 |
| 21 | Truncal ataxia (HP:0002078) | 3.09362399 |
| 22 | Dysmetria (HP:0001310) | 3.05663672 |
| 23 | Epileptiform EEG discharges (HP:0011182) | 3.05071553 |
| 24 | Abnormal eating behavior (HP:0100738) | 2.95560190 |
| 25 | Syncope (HP:0001279) | 2.95086535 |
| 26 | Excessive salivation (HP:0003781) | 2.93862620 |
| 27 | Drooling (HP:0002307) | 2.93862620 |
| 28 | Anxiety (HP:0000739) | 2.91525321 |
| 29 | Bundle branch block (HP:0011710) | 2.89130549 |
| 30 | Obstructive sleep apnea (HP:0002870) | 2.88256535 |
| 31 | Scanning speech (HP:0002168) | 2.87813449 |
| 32 | Depression (HP:0000716) | 2.82885591 |
| 33 | Action tremor (HP:0002345) | 2.82518042 |
| 34 | Dysmetric saccades (HP:0000641) | 2.79372048 |
| 35 | Progressive inability to walk (HP:0002505) | 2.74452190 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.73891176 |
| 37 | Impaired smooth pursuit (HP:0007772) | 2.68262356 |
| 38 | Stereotypic behavior (HP:0000733) | 2.67846962 |
| 39 | EEG with generalized epileptiform discharges (HP:0011198) | 2.65397364 |
| 40 | Inability to walk (HP:0002540) | 2.62644490 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.57860002 |
| 42 | Supranuclear gaze palsy (HP:0000605) | 2.57518612 |
| 43 | Status epilepticus (HP:0002133) | 2.57354842 |
| 44 | Absent speech (HP:0001344) | 2.55454639 |
| 45 | Protruding tongue (HP:0010808) | 2.55215099 |
| 46 | Sudden death (HP:0001699) | 2.55146439 |
| 47 | Postural instability (HP:0002172) | 2.49928313 |
| 48 | Fetal akinesia sequence (HP:0001989) | 2.46834030 |
| 49 | Genetic anticipation (HP:0003743) | 2.46281767 |
| 50 | Ankle clonus (HP:0011448) | 2.44700600 |
| 51 | Hemiparesis (HP:0001269) | 2.44677012 |
| 52 | Abnormality of binocular vision (HP:0011514) | 2.42917940 |
| 53 | Diplopia (HP:0000651) | 2.42917940 |
| 54 | Hypsarrhythmia (HP:0002521) | 2.40526388 |
| 55 | Annular pancreas (HP:0001734) | 2.35154735 |
| 56 | Bradykinesia (HP:0002067) | 2.34966272 |
| 57 | Torticollis (HP:0000473) | 2.34375761 |
| 58 | Generalized myoclonic seizures (HP:0002123) | 2.32062794 |
| 59 | Neurofibrillary tangles (HP:0002185) | 2.31035657 |
| 60 | Ventricular fibrillation (HP:0001663) | 2.30343582 |
| 61 | Resting tremor (HP:0002322) | 2.28051953 |
| 62 | Impaired vibratory sensation (HP:0002495) | 2.27334439 |
| 63 | Sleep apnea (HP:0010535) | 2.26829267 |
| 64 | Urinary urgency (HP:0000012) | 2.26808211 |
| 65 | Prolonged QT interval (HP:0001657) | 2.26519466 |
| 66 | Blue irides (HP:0000635) | 2.25899842 |
| 67 | Abnormality of the lower motor neuron (HP:0002366) | 2.25618270 |
| 68 | Tetraplegia (HP:0002445) | 2.23164244 |
| 69 | Focal dystonia (HP:0004373) | 2.23147640 |
| 70 | Gait imbalance (HP:0002141) | 2.21668924 |
| 71 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.21135133 |
| 72 | Primary atrial arrhythmia (HP:0001692) | 2.20196251 |
| 73 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.19967925 |
| 74 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.19967925 |
| 75 | Insidious onset (HP:0003587) | 2.18681073 |
| 76 | Termporal pattern (HP:0011008) | 2.18681073 |
| 77 | Akinesia (HP:0002304) | 2.18369230 |
| 78 | Abnormal EKG (HP:0003115) | 2.15202011 |
| 79 | Polyphagia (HP:0002591) | 2.14784196 |
| 80 | Cerebral hypomyelination (HP:0006808) | 2.13840122 |
| 81 | Atrial fibrillation (HP:0005110) | 2.12788528 |
| 82 | Mutism (HP:0002300) | 2.12728264 |
| 83 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11307485 |
| 84 | Heart block (HP:0012722) | 2.10518285 |
| 85 | Spastic gait (HP:0002064) | 2.09635049 |
| 86 | Supraventricular tachycardia (HP:0004755) | 2.08256348 |
| 87 | Incomplete penetrance (HP:0003829) | 2.07992522 |
| 88 | Hemiplegia (HP:0002301) | 2.05075698 |
| 89 | Pheochromocytoma (HP:0002666) | 2.04142311 |
| 90 | Neuronal loss in central nervous system (HP:0002529) | 2.04104782 |
| 91 | Clonus (HP:0002169) | 2.03962015 |
| 92 | Limb dystonia (HP:0002451) | 2.02680470 |
| 93 | Supraventricular arrhythmia (HP:0005115) | 2.00405326 |
| 94 | Thickened helices (HP:0000391) | 1.99509990 |
| 95 | Spastic tetraparesis (HP:0001285) | 1.97581066 |
| 96 | Craniofacial dystonia (HP:0012179) | 1.97308945 |
| 97 | Congenital primary aphakia (HP:0007707) | 1.97115026 |
| 98 | Gait ataxia (HP:0002066) | 1.95461533 |
| 99 | Abnormality of salivation (HP:0100755) | 1.94856867 |
| 100 | Delusions (HP:0000746) | 1.91044222 |
| 101 | Papilledema (HP:0001085) | 1.90105497 |
| 102 | Agnosia (HP:0010524) | 1.87352205 |
| 103 | Lower limb muscle weakness (HP:0007340) | 1.86787361 |
| 104 | Medial flaring of the eyebrow (HP:0010747) | 1.86336524 |
| 105 | Increased circulating renin level (HP:0000848) | 1.86072756 |
| 106 | Rigidity (HP:0002063) | 1.82521798 |
| 107 | Intention tremor (HP:0002080) | 1.82140104 |
| 108 | Neuroendocrine neoplasm (HP:0100634) | 1.81708961 |
| 109 | Spastic tetraplegia (HP:0002510) | 1.81589400 |
| 110 | Specific learning disability (HP:0001328) | 1.81489014 |
| 111 | Fair hair (HP:0002286) | 1.81091015 |
| 112 | Generalized hypopigmentation of hair (HP:0011358) | 1.80907239 |
| 113 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80840183 |
| 114 | Abnormal hair whorl (HP:0010721) | 1.79055634 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.77108433 |
| 116 | Lower limb asymmetry (HP:0100559) | 1.76370499 |
| 117 | Abnormality of the corticospinal tract (HP:0002492) | 1.75464271 |
| 118 | Psychosis (HP:0000709) | 1.71977903 |
| 119 | Hyperthyroidism (HP:0000836) | 1.71712287 |
| 120 | Abnormality of saccadic eye movements (HP:0000570) | 1.70884078 |
| 121 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.68663340 |
| 122 | Deeply set eye (HP:0000490) | 1.67800251 |
| 123 | Ankyloglossia (HP:0010296) | 1.66679607 |
| 124 | Absent/shortened dynein arms (HP:0200106) | 1.64379470 |
| 125 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.64379470 |
| 126 | Dyskinesia (HP:0100660) | 1.63714943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.82466169 |
| 2 | NTRK3 | 4.78430562 |
| 3 | CASK | 3.80550026 |
| 4 | MAP3K9 | 3.27141177 |
| 5 | DAPK2 | 2.83863085 |
| 6 | MAP3K4 | 2.81485117 |
| 7 | RIPK4 | 2.75730926 |
| 8 | MAP2K7 | 2.69160814 |
| 9 | MAP3K12 | 2.31124112 |
| 10 | MINK1 | 2.17456134 |
| 11 | DAPK1 | 2.08851749 |
| 12 | PLK2 | 2.05741343 |
| 13 | KSR2 | 1.96418877 |
| 14 | MAP2K4 | 1.85898865 |
| 15 | KSR1 | 1.78541732 |
| 16 | MARK1 | 1.77834812 |
| 17 | CDK19 | 1.72907475 |
| 18 | TNIK | 1.68353195 |
| 19 | NTRK2 | 1.68331471 |
| 20 | PRPF4B | 1.68054532 |
| 21 | ARAF | 1.66037702 |
| 22 | FRK | 1.56210440 |
| 23 | PAK6 | 1.49877564 |
| 24 | MAP3K13 | 1.49409489 |
| 25 | NTRK1 | 1.43656130 |
| 26 | CDK5 | 1.41125019 |
| 27 | CAMKK1 | 1.32940228 |
| 28 | GRK5 | 1.30517558 |
| 29 | BMPR2 | 1.27661321 |
| 30 | FES | 1.26925491 |
| 31 | PNCK | 1.24261255 |
| 32 | PRKCG | 1.20950246 |
| 33 | CCNB1 | 1.19054166 |
| 34 | SIK2 | 1.15984795 |
| 35 | CAMKK2 | 1.15972254 |
| 36 | CAMK2A | 1.15606569 |
| 37 | MAPK13 | 1.13946918 |
| 38 | CAMK2B | 1.13304144 |
| 39 | PTK2B | 1.10642687 |
| 40 | PRKD3 | 1.10523893 |
| 41 | RAF1 | 1.05483471 |
| 42 | AKT3 | 1.04987858 |
| 43 | NME1 | 1.04958233 |
| 44 | OXSR1 | 1.04282702 |
| 45 | MAP3K2 | 0.88258054 |
| 46 | SGK223 | 0.86706283 |
| 47 | SGK494 | 0.86706283 |
| 48 | CDK18 | 0.86095803 |
| 49 | SIK3 | 0.85871560 |
| 50 | SGK2 | 0.85539488 |
| 51 | STK38 | 0.83992236 |
| 52 | CDK15 | 0.80818372 |
| 53 | CDK14 | 0.78443873 |
| 54 | SGK1 | 0.76763777 |
| 55 | BRAF | 0.74506962 |
| 56 | CAMK1 | 0.74244562 |
| 57 | PIK3CA | 0.69820251 |
| 58 | CDK11A | 0.69425629 |
| 59 | WNK1 | 0.67360250 |
| 60 | UHMK1 | 0.66478883 |
| 61 | MARK2 | 0.65136819 |
| 62 | FGR | 0.64327979 |
| 63 | DYRK1A | 0.63718306 |
| 64 | PRKCE | 0.62206213 |
| 65 | PINK1 | 0.59834824 |
| 66 | TYRO3 | 0.59273447 |
| 67 | STK11 | 0.59244041 |
| 68 | PKN1 | 0.58084740 |
| 69 | CSNK1G2 | 0.57629060 |
| 70 | MAPKAPK5 | 0.57005636 |
| 71 | PDK1 | 0.56372696 |
| 72 | PRKCH | 0.55782983 |
| 73 | SGK3 | 0.55687626 |
| 74 | PDPK1 | 0.55000067 |
| 75 | CAMK2D | 0.53919171 |
| 76 | MAP3K1 | 0.53188148 |
| 77 | DAPK3 | 0.53061366 |
| 78 | MAP2K1 | 0.48796315 |
| 79 | TNK2 | 0.48209444 |
| 80 | TAOK1 | 0.47119304 |
| 81 | STK39 | 0.45827164 |
| 82 | RET | 0.45808271 |
| 83 | CAMK2G | 0.45763899 |
| 84 | ALK | 0.45106968 |
| 85 | MAP3K11 | 0.43781862 |
| 86 | PDK4 | 0.43549679 |
| 87 | PDK3 | 0.43549679 |
| 88 | MUSK | 0.43041119 |
| 89 | INSRR | 0.42857962 |
| 90 | CSNK1D | 0.41705135 |
| 91 | RPS6KA3 | 0.41574807 |
| 92 | MAPK12 | 0.40983798 |
| 93 | PRKCA | 0.40909710 |
| 94 | NEK6 | 0.39626282 |
| 95 | FER | 0.39500782 |
| 96 | PRKG1 | 0.39147973 |
| 97 | DMPK | 0.38892399 |
| 98 | GRK7 | 0.38823914 |
| 99 | BCR | 0.38572429 |
| 100 | PRKCZ | 0.37898887 |
| 101 | PRKCB | 0.37048669 |
| 102 | WNK3 | 0.36970669 |
| 103 | PHKG1 | 0.36426643 |
| 104 | PHKG2 | 0.36426643 |
| 105 | FYN | 0.36170909 |
| 106 | LATS2 | 0.34891480 |
| 107 | MAP3K6 | 0.34225734 |
| 108 | ADRBK2 | 0.33976741 |
| 109 | MOS | 0.33829771 |
| 110 | CAMK4 | 0.33702132 |
| 111 | PRKACA | 0.33645632 |
| 112 | MAP3K7 | 0.33419280 |
| 113 | MAPK7 | 0.33088800 |
| 114 | PAK3 | 0.33086992 |
| 115 | MAPK10 | 0.31072628 |
| 116 | ROCK2 | 0.30657519 |
| 117 | LIMK1 | 0.30464669 |
| 118 | CSNK1A1 | 0.29273337 |
| 119 | PRKACB | 0.28493608 |
| 120 | CSNK1E | 0.28014491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nicotine addiction_Homo sapiens_hsa05033 | 4.13479428 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.38119251 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.99369242 |
| 4 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.91769773 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.86434530 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.77485918 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.76068534 |
| 8 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.71755946 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.68317030 |
| 10 | * Morphine addiction_Homo sapiens_hsa05032 | 2.67538702 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.31942919 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28494377 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.22395087 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92736185 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.92105045 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.91748383 |
| 17 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.81586577 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.81157912 |
| 19 | * Taste transduction_Homo sapiens_hsa04742 | 1.80751582 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78220534 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.77833814 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77704537 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76927140 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72811280 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.71709845 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54166588 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35036017 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34497770 |
| 29 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.33769047 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.30039381 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29996488 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22762745 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16301641 |
| 34 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.15022278 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10915515 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10193850 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09398747 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09138778 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07885399 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06861455 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04485776 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99938722 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 0.98589394 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98190400 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96518582 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.95770305 |
| 47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94951816 |
| 48 | Glioma_Homo sapiens_hsa05214 | 0.92258587 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91241985 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.90457587 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88403440 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84505641 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83775394 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83051131 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77275242 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76677519 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68124017 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67192097 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66775588 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66596584 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64339319 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.62909849 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62107873 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61433833 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59782190 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58859712 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58112560 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56862799 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56607854 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56303132 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55113069 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54835314 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50230038 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49771841 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48928756 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48359935 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47686609 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.47220205 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46956360 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43226650 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41552990 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39122299 |
| 83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37875968 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36804338 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36102649 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34917738 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34180034 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.34136153 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33176962 |
| 90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31737297 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31171980 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30961495 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.30678726 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29903571 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29498705 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.28767193 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28505505 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28124720 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26538950 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26487002 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26384892 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24997728 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22668024 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21626943 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.20984933 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.19458568 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.19411028 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18809192 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18770397 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.18346395 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18341703 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.17451371 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14149371 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.13968046 |

